Review demonstrates glycoRNA's role in immune regulation in tumors, suggesting it as a potential therapeutic target.
糖基化RNA(glycoRNA)是近年来新发现的一类RNA修饰形式,其在肿瘤免疫调控中的作用日益受到关注。本文系统综述了glycoRNA的生物合成途径、细胞表面定位及其在肿瘤免疫微环境中的潜在功能,重点探讨了其通过多种机制调控免疫应答的过程,包括:glycoRNA-Siglec互作介导的免疫逃逸、“糖链帽”-acp³U结构对免疫激活的调节、代谢与免疫的偶联、小型胞外囊泡(small extracellular vesicle, sEV)介导的远程免疫抑制,以及对免疫细胞功能的直接影响。此外,文章也总结了针对glycoRNA及相关通路的检测技术进展,并展望了其作为新型生物标志物及治疗靶点的潜力,以期为发展基于glycoRNA的肿瘤免疫治疗策略提供理论依据。
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: